Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists

被引:58
|
作者
Berg, KA
Maayani, S
Goldfarb, J
Clarke, WP
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78284 USA
[2] Mt Sinai Med Ctr, Dept Anesthesiol, New York, NY 10029 USA
[3] Mt Sinai Med Ctr, Dept Pharmacol, New York, NY 10029 USA
来源
ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS | 1998年 / 861卷
关键词
D O I
10.1111/j.1749-6632.1998.tb10180.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is now considerable evidence that a single receptor subtype can couple to multiple effector pathways within a cell. Recently, Kenakin proposed a new concept, termed "agonist-directed trafficking of receptor stimulus", that suggests that agonists may be able to selectively activate a subset of multiple signaling pathways coupled to a single receptor subtype. 5-HT2A and 5-HT2C receptors couple to phospholipase C-(PLC) mediated inositol phosphate (IP) accumulation and PLA(2)-mediated arachidonic acid (AA) release. Relative efficacies of agonists (referenced to 5-HT) differed depending upon whether LP accumulation or AA release aas measured. For the 5-HT2C receptor system, some agonists (e.g. TFMPP) preferentially activated the PLC-IP pathway, whereas others (e.g. LSD) favored PLA(2)-AA. As expected, EC50's of agonists did not differ between pathways, For the 5-HT2A receptor system, all agonists tested had greater relative efficacy for PLA(2)-AA than for PLC-LP. In contrast, relative efficacies were not different for 5-HT2A agonists when sequential effects in a pathway were measured (IP accumulation vs. calcium mobilization). These data strongly support the agonist-directed trafficking hypothesis.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 50 条
  • [1] A comparison of the behavioural effects of 5-HT2A and 5-HT2C receptor agonists in the pigeon
    Wolff, MC
    Leander, JD
    BEHAVIOURAL PHARMACOLOGY, 2000, 11 (05): : 355 - 364
  • [2] 5-HT2A and 5-HT2C receptor stimulation are differentially involved in the cortical dopamine release in 5-HT2A and 5-HT2C genetic mutant mice
    Huang, M.
    Li, Z.
    Prus, A. J.
    Dai, J.
    Meltzer, H. Y.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 317 - 318
  • [3] Imaging the 5-HT2C receptor with PET: Evaluation of 5-HT2C and 5-HT2A affinity of pimavanserin in the primate brain
    Ridler, Khanum
    Rizzo, Gaia
    Burstein, Ethan S.
    Forsberg Moren, Anton
    Stepanov, Vladimir
    Halldin, Christer
    Rabiner, Eugenii A.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2025, 45 (02): : 352 - 364
  • [4] Biophysical identification of the 5-HT2A receptor: 5-HT2C receptor interaction in vitro
    Felsing, Daniel Eric
    Anastasio, Noelle C.
    Miszkiel, Joanna M.
    Gilbertson, Scott
    Moeller, Frederick Gerrard
    Allen, John A.
    Cunningham, Kathryn A.
    FASEB JOURNAL, 2018, 32 (01):
  • [5] Exploration of the 5-HT2A: 5-HT2C receptor protein complex in vitro
    Felsing, Daniel E.
    Anastasio, Noelle C.
    Gilbertson, Scott R.
    Moeller, Gerard F.
    Cunningham, Kathryn A.
    Allen, John A.
    FASEB JOURNAL, 2017, 31
  • [6] Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction
    Felsing, Daniel E.
    Anastasio, Noelle C.
    Miszkiel, Joanna M.
    Gilbertson, Scott R.
    Allen, John A.
    Cunningham, Kathryn A.
    PLOS ONE, 2018, 13 (08):
  • [7] 5-HT2A and 5-HT2C receptor stimulation are differentially involved in the cortical dopamine efflux-Studied in 5-HT2A and 5-HT2C genetic mutant mice
    Huang, Mei
    Dai, Jin
    Meltzer, Herbert Y.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 652 (1-3) : 40 - 45
  • [8] New 5-HT2c receptor agonists
    Bishop, MJ
    Nilsson, BM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (11) : 1691 - 1705
  • [9] Effect of reserpine on behavioural responses to agonists at 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor subtypes
    Heslop, KE
    Curzon, G
    NEUROPHARMACOLOGY, 1999, 38 (06) : 883 - 891
  • [10] Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in the generalization of 5-HT receptor agonists to the ethanol cue in the rat
    Maurel, S
    Schreiber, R
    De Vry, J
    BEHAVIOURAL PHARMACOLOGY, 1998, 9 (04): : 337 - 343